Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
F. Kamal (London, United Kingdom), S. Kumar (London, United Kingdom), A. Singanayagam (London, United Kingdom), M. Edwards (London, United Kingdom), A. Romano (London, United Kingdom), K. Veslkov (London, United Kingdom), I. Laponogov (London, United Kingdom), G. Donaldson (London, United Kingdom), S. Johnston (London, United Kingdom), J. Wedzicha (London, United Kingdom), G. Hanna (London, United Kingdom). Volatile organic compound (VOC) analysis to differentiate between bacterial and viral respiratory infections in COPD. 5301

Member's Comments

No comment yet.

Related content which might interest you: Volatile organic compounds (VOCs) in COPD patients with exacerbation Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Integrating monitoring of volatile organic compounds (VOCs) in asthma and COPD into the routine lung function Source: International Congress 2015 – The next generation of lung function tests Year: 2015 Volatile organic compounds (VOC) in exhaled breath of patients with COPD Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 Multiple detectable exhaled volatile organic compounds (vocs) may serve as potential inflammatory biomarkers in COPD Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Microbial volatile organic compounds (MVOC) and plasticizers in schools in relation to asthma and respiratory symptoms among pupils Source: Eur Respir J 2006; 28: Suppl. 50, 698s Year: 2006 Lower respiratory tract infection (LRTI): are there differences of microbial spectrum in stable phase (SP) of COPD and during acute exacerbation (AE)? Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 Identification of exhaled volatile organic compounds (VOCs) associated with loss of asthma control Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Volatile organic compounds (VOCs) in exhaled air of patients with lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 208s Year: 2003 Breath volatile organic compound (VOC) patterns in adult asthma patients of the ALLIANCE cohort Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 Wheeze, current asthma and respiratory infections among students in Malaysian schools - assocations with formaldehyde, nitrogen dioxide and specific volatile organic compounds (VOC) in classroom air Source: International Congress 2017 – The air indoor air pollution Year: 2017 Combined effect of volatile organic compounds on respiratory health in adults Source: Annual Congress 2010 - Indoor air and respiratory disease Year: 2010 Breath volatile organic compound (VOC) COPD study at two DZL centers - Evaluation of site-specific VOC Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Volatile organic compounds in exhaled breath are associated with exacerbations in children with asthma Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Spectrum of bacterial and viral pathogens of infectious exacerbation of COPD Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008 Biomarkers to discriminate bacterial, viral and mixed community acquired pneumonia (CAP) Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD Source: Eur Respir J 2011; 38: 1301-1309 Year: 2011 Exposure to volatile organic compounds and loss of pulmonary function in the elderly Source: Eur Respir J 2010; 36: 1270-1276 Year: 2010 Volatile organic compounds (VOC) in exhaled air sampled through the working channel of a bronchoscope in lung cancer patients Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Volatile organic compounds in COPD: Is hexanal an inflammation biomarker? Source: International Congress 2016 – The future of lung function is beginning now Year: 2016